Phoenix viewer faster4/15/2023 GlobalSubmit WebReview was built with ease-of-use in mind to facilitate a timely review across your various stakeholders responsible for approving specific content in your eCTD submissions (CMC, clinical, non-clinical, etc.). Ideal for publishers in your organization needing to do a granular review of your eCTD submissions and quality control (QC) of your hyperlinks and bookmarks. Ideal for most stakeholders across your organization needing to review specific content of your eCTD submissions. The trouble is, without the right eCTD viewing software in place, simple yet critical review tasks can cause delays, increasing your risk of rejection, costs, and user frustration.Ĭertara’s GlobalSubmit WebReview and REVIEW were designed with these challenges in mind to help you facilitate the timely review of your eCTD submissions across your stakeholders. They are responsible for approving eCTD submission content quickly, fielding agency questions on the fly, and often require referencing in-stream as well as historical submissions to do so. We have often found that organizations have numerous stakeholders responsible for reviewing the content of their drug submissions. ![]() Not to mention, avoiding major mistakes that push back submission dates and staying on budget. If you’re like most regulatory professionals, you’re spending your time on meeting your organization’s goals on expediting its development to market by filing regulatory submissions as fast and as accurately as possible. Let’s face it, reviewing your eCTD submissions is a cumbersome, and sometimes daunting task. Simplified eCTD submission review for a complex regulatory world
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |